In conclusion, this study demonstrates that elevated expression of lncRNA CBR3-AS1 may be linked to reduced overall survival in cancer patients, as well as associations with lymph node metastasis, advanced TNM stage, and increased tumor size. Here, CBR3 is linked to metastatic malignant neoplasm in the lymph nodes.